
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 独立董事提名人声明与承诺(范宏宇) | 2025-09-28 | Chinese | |
| 第四届董事会第四十五次会议决议公告 | 2025-09-28 | Chinese | |
| 独立董事候选人声明与承诺(范宏宇) | 2025-09-28 | Chinese | |
| 独立董事提名人声明与承诺(刘榜) | 2025-09-28 | Chinese | |
| 关于董事会换届选举的公告 | 2025-09-28 | Chinese | |
| 董事和高级管理人员持股及其变动管理办法(2025年09月修订) | 2025-09-28 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 38199521 | 独立董事提名人声明与承诺(范宏宇) | 2025-09-28 | Chinese | ||
| 38199508 | 第四届董事会第四十五次会议决议公告 | 2025-09-28 | Chinese | ||
| 38199498 | 独立董事候选人声明与承诺(范宏宇) | 2025-09-28 | Chinese | ||
| 38199481 | 独立董事提名人声明与承诺(刘榜) | 2025-09-28 | Chinese | ||
| 38199467 | 关于董事会换届选举的公告 | 2025-09-28 | Chinese | ||
| 38199453 | 董事和高级管理人员持股及其变动管理办法(2025年09月修订) | 2025-09-28 | Chinese | ||
| 38199437 | 关于提前归还部分暂时用于补充流动资金的闲置募集资金的公告 | 2025-09-23 | Chinese | ||
| 38199432 | 关于参加重庆辖区上市公司2025年投资者网上集体接待日活动的公告 | 2025-09-17 | Chinese | ||
| 38199418 | 关于公司2025年度对外担保预计的进展公告 | 2025-09-16 | Chinese | ||
| 38199405 | 2025年第三次临时股东大会决议公告 | 2025-09-11 | Chinese | ||
| 38199396 | 上海市锦天城律师事务所关于天域生物科技股份有限公司2025年第三次临时股东大会的法律意见书 | 2025-09-11 | Chinese | ||
| 38199306 | 关于2025年半年度业绩说明会召开情况的公告 | 2025-09-10 | Chinese | ||
| 38199294 | 控股股东、实际控制人关于《天域生物科技股份有限公司股票交易异常波动的问询函》的回复 | 2025-09-09 | Chinese | ||
| 38199281 | 股票交易异常波动公告 | 2025-09-09 | Chinese | ||
| 38199273 | 2025年8月养殖业务主要经营数据公告 | 2025-09-05 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.